It mainly explored the dynamics, biomarkers, risk factors, and mechanism of severe CRS(sCRS) in CD19-CAR-T cell therapy, and the tenth-ranked paper (strength: 50.69) was published by Fry et al. (94) in Nature Medicine in 2018. The gene discussed is CD19; the disease is congenital rubella syndrome.